{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:23:47Z","timestamp":1770434627354,"version":"3.49.0"},"reference-count":52,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,7,27]],"date-time":"2007-07-27T00:00:00Z","timestamp":1185494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:sec><jats:label\/><jats:p> <jats:bold>What is already known about this subject<\/jats:bold> <\/jats:p><jats:p>\u2022\u2002Ciclosporin is an immunosuppressant drug with a narrow therapeutic index and large variability in pharmacokinetics.<\/jats:p><jats:p>\u2022\u2002It is likely that the inter\u2010 and intraindividual variability in ciclosporin pharmacokinetics and dose requirements is even larger in children than in adults as a result of variation in biological maturation status.<\/jats:p><jats:p>\u2022\u2002However, data on the developmental pharmacokinetics of ciclosporin, as well as other CYP3A4 substrate drugs, in children are scarce.<\/jats:p><jats:p> <jats:bold>What this study adds<\/jats:bold> <\/jats:p><jats:p>\u2022\u2002Adult CYP3A4 activity seems to be reached by the age of 6\u201312\u2003months, and allometrically scaled body weight is a good predictor of the hepatic clearance of ciclosporin, a CYP3A4 substrate.<\/jats:p><jats:p>\u2022\u2002Ciclosporin oral bioavailability, known previously to display large interindividual variability, is not influenced by age.<\/jats:p><jats:p>\u2022\u2002These conclusions were reached using a robust modelling approach (NONMEM) with rich paediatric pharmacokinetic data collected after full i.v. and p.o. profiles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To use population pharmacokinetic modelling to characterize the influence of developmental and demographic factors on the pharmacokinetic variability of ciclosporin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Pharmacokinetic modelling was performed in NONMEM using a dataset comprising 162 pretransplant children, aged 0.36\u201317.5\u2003years. Ciclosporin was given intravenously (3\u2003mg\u2003kg<jats:sup>\u22121<\/jats:sup>) and orally (10\u2003mg\u2003kg<jats:sup>\u22121<\/jats:sup>) on separate occasions followed by blood sampling for 24\u2003h.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A three\u2010compartment model with first\u2010order absorption without lag\u2010time best described the pharmacokinetics of ciclosporin. The most important covariate affecting systemic clearance (CL) and distribution volume (<jats:italic>V<\/jats:italic>) was body weight (BW; scaled allometrically), responsible for a fourfold difference in uncorrected ciclosporin CL and a sixfold difference in ciclosporin <jats:italic>V<\/jats:italic>. The other significant covariates, haematocrit, plasma cholesterol and creatinine, were estimated to explain 20\u201330% of interindividual differences in CL and <jats:italic>V<\/jats:italic> of ciclosporin. No age\u2010related changes in oral bioavailability or in BW\u2010normalized <jats:italic>V<\/jats:italic> were seen. The BW\u2010normalized CL (CL\/BW) declined with age and prepubertal children (&lt;8\u2003years) had an approximately 25% higher CL\/BW than did older children. Normalization of CL for allometric BW (BW<jats:sup>3\/4<\/jats:sup>) removed its relationship to age.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The relationship between CL and allometric BW is consistent with a gradual reduction in relative liver size, until adult values, and a relatively constant CYP3A4 content in the liver from about 6\u201312\u2003months of age to adulthood. Ciclosporin oral bioavailability, known previously to display large interindividual variability, is not influenced by age. These findings can enable better individualization of ciclosporin dosing in infants, children and adolescents.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2125.2007.03003.x","type":"journal-article","created":{"date-parts":[[2007,7,27]],"date-time":"2007-07-27T14:15:57Z","timestamp":1185545757000},"page":"772-784","source":"Crossref","is-referenced-by-count":61,"title":["Developmental pharmacokinetics of ciclosporin \u2013 a population pharmacokinetic study in paediatric renal transplant candidates"],"prefix":"10.1111","volume":"64","author":[{"given":"S.","family":"Fanta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. T.","family":"Backman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. O.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hoppu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7,27]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198912213212507"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01046702"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241090-00001"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90027-8"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90168-X"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1991.tb03934.x"},{"key":"e_1_2_6_8_2","first-page":"120","article-title":"Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites","volume":"12","author":"Maurer G","year":"1984","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389200023337630"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241020-00004"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199732060-00004"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)02074-0"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199512000-00013"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.132"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199111000-00001"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199609150-00010"},{"key":"e_1_2_6_17_2","first-page":"837","article-title":"Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations","volume":"27","author":"Schroeder TJ","year":"1995","journal-title":"Transplant Proc"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)00737-4"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.01.091"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199937060-00004"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645010-00001"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00852828"},{"key":"e_1_2_6_23_2","volume-title":"NONMEM Users Guide Part I \u2013 Users Basic Guide.","author":"Beal SL","year":"1989"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011527125570"},{"key":"e_1_2_6_25_2","unstructured":"SavicR JonkerDM KerbuschT KarlssonMO.Evaluation of a transit compartment model versus a lag time model for describing drug absorption delay. PAGE abstracts of the Annual Meeting of the Population Approach Group in Europe2004."},{"key":"e_1_2_6_26_2","first-page":"225","article-title":"Estimation of human body surface area from height and weight","volume":"54","author":"Gehan EA","year":"1970","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199630050-00001"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01061662"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01113502"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4541-9"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2005.04.005"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1802-8"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20519"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.004358"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.174"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198611020-00002"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.08.022"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj070248"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1472-8206.2003.00140.x"},{"key":"e_1_2_6_40_2","first-page":"414","article-title":"Interindividual variations in human liver cytochrome P\u2010450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada T","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.87"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1997.00625.x"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199712000-00002"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02225.x"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1890\/03-0757"},{"key":"e_1_2_6_46_2","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511608551","volume-title":"The Ecological Implications of Body Size.","author":"Peters RH.","year":"1983"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006060610"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1994.tb03967.x"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199223030-00002"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(01)00570-8"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2005.00683.x"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00474-3"},{"key":"e_1_2_6_53_2","first-page":"16","article-title":"A longitudinal study of the pharmacokinetics of cyclosporine A and in vitro lymphocyte responses in renal transplant patients","volume":"18","author":"Tufveson G","year":"1986","journal-title":"Transplant Proc"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.2007.03003.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.2007.03003.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:33:06Z","timestamp":1697441586000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2007.03003.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,27]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1365-2125.2007.03003.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.2007.03003.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,27]]}}}